SCHEMBL7144340

SCHEMBL7144340

COCN1c2cc(C(=O)CBr)ccc2Sc2nccnc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 3/20 0.42
GSK3B P49841 3/20 0.35
TP53 P04637 3/20 0.34
CHRM2 P08172 2/20 0.34
HTR1A P08908 2/20 0.34
CHRM1 P11229 2/20 0.34
DRD2 P14416 2/20 0.34
ADRA1A P35348 2/20 0.34
OPRM1 P35372 2/20 0.34
DRD3 P35462 2/20 0.34
KCNH2 Q12809 2/20 0.34
CYP1A2 P05177 2/20 0.34
CYP2D6 P10635 2/20 0.34
TSHR P16473 2/20 0.34
ADRA2B P18089 1/20 0.34
ADRA2C P18825 1/20 0.34
CHRM3 P20309 1/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HRH1 P35367 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8315505 0.89 HDAC6 (0.45) HDAC6TP53CHRM2HTR1ACHRM1
SCHEMBL6745150 0.88 HDAC6 (0.44) HDAC6TP53CHRM2HTR1ACHRM1
SCHEMBL6747463 0.88 HDAC6 (0.44) HDAC6GSK3BCHRM2HTR1ACHRM1
SCHEMBL6747555 0.88 HDAC6 (0.44) HDAC6TP53HRH1MEN1KMT2A
SCHEMBL6745834 0.87 HDAC6 (0.43) HDAC6TP53CHRM2HTR1ACHRM1
SCHEMBL6747320 0.85 HDAC6 (0.57) HDAC6TP53HDAC3HDAC1
SCHEMBL6746495 0.84 HDAC6 (0.43) HDAC6TP53CHRM2HTR1ACHRM1
SCHEMBL6751846 0.82 HDAC6 (0.39) HDAC6CYP1A2TSHRTHRBLMNA
SCHEMBL6848543 0.81 HDAC6 (0.43) HDAC6TP53CHRM2HTR1ACHRM1
SCHEMBL6750196 0.81 HDAC6 (0.44) HDAC6MEN1KMT2ASMN1; SMN2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6518423-B1 These compounds are useful as drugs efficacious in the prevention and treatment of these various inflammatory diseases and immunologic diseases, such as rheumatoid arthritis, atopic dermatitis, psoriasis, asthma, and EISAI CO., LTD. (JP) 2003-02-11 US disclosed
EP-0934941-A1 BENZOPIPERIDINE DERIVATIVES Eisai Co., Ltd. (JP) 1999-08-11 EP disclosed